On the Frontlines of Metastatic Breast Cancer - Global Women's Health Academy

1-16 of 23

Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Interpreting Oral SERD Trial Data in Metastatic Breast Cancer
Alexandria May, PharmD, BCPS; Donald McDonnell, PhD
- Alexandria May, PharmD, BCPS
- Donald McDonnell, PhD
- Neil M. Iyengar, MD
Advancing Metastatic Breast Cancer Research Through Philanthropy
Advancing Metastatic Breast Cancer Research Through Philanthropy
On the Frontlines of Metastatic Breast Cancer
Advancing Metastatic Breast Cancer Research Through Philanthropy
Steve Jackson, PharmD; Ted Giovanis, FHFMA, MBA
- Steve Jackson, PharmD
- Ted Giovanis, FHFMA, MBA
Real-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
Real-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
On the Frontlines of Metastatic Breast Cancer
Real-World Sacituzumab Govitecan Reinforces Benefit in mTNBC
Ryan Quigley
- Ryan Quigley
MCED Testing for Breast Cancer: Opportunities and Limitations
MCED Testing for Breast Cancer: Opportunities and Limitations
On the Frontlines of Metastatic Breast Cancer
MCED Testing for Breast Cancer: Opportunities and Limitations
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
How Genetic Testing Guides Personalized mBC Care
How Genetic Testing Guides Personalized mBC Care
On the Frontlines of Metastatic Breast Cancer
How Genetic Testing Guides Personalized mBC Care
Alexandria May, PharmD, BCPS; Marie Wood, MD
- Alexandria May, PharmD, BCPS
- Marie Wood, MD
Protecting Heart Health in Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Protecting Heart Health in Metastatic Breast Cancer
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
The Past, Present, and Future of Metastatic Breast Cancer Care
The Past, Present, and Future of Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
The Past, Present, and Future of Metastatic Breast Cancer Care
Ryan Quigley; Gregory Vidal, MD, PhD
- Ryan Quigley
- Gregory Vidal, MD, PhD
Addressing Unmet Needs in First-Line mTNBC Care
Addressing Unmet Needs in First-Line mTNBC Care
On the Frontlines of Metastatic Breast Cancer
Addressing Unmet Needs in First-Line mTNBC Care
Jennifer Caudle, DO, FACOFP; Alexis Ann LeVee, MD
- Jennifer Caudle, DO, FACOFP
- Alexis Ann LeVee, MD
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Biomarker-Guided Treatment in ER+, HER2- Metastatic Breast Cancer
Maxwell Llyod, MD; Ryan Quigley
- Maxwell Llyod, MD
- Ryan Quigley
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
On the Frontlines of Metastatic Breast Cancer
HER2-Positive Breast Cancer and the Challenge of Brain Metastases
Charles Turck, PharmD, BCPS, BCCCP; Heather Parsons
- Charles Turck, PharmD, BCPS, BCCCP
- Heather Parsons
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
On the Frontlines of Metastatic Breast Cancer
How ctDNA and Liquid Biopsy Are Shaping Early Detection of Breast Cancer Progression
Ashley Baker, MSN, PMHNP; Nick McAndrew, MD, MSCE
- Ashley Baker, MSN, PMHNP
- Nick McAndrew, MD, MSCE
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Modern Approaches to Long-Term Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
Modern Approaches to Long-Term Metastatic Breast Cancer Care
Charles Turck, PharmD, BCPS, BCCCP; Adam Brufsky, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- Adam Brufsky, MD, PhD
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
On the Frontlines of Metastatic Breast Cancer
Exploring T-DXd in HER2-Positive Breast Cancer Treatment
Charles Turck, PharmD, BCPS, BCCCP; Jules Cohen, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Jules Cohen, MD
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
On the Frontlines of Metastatic Breast Cancer
DESTINY-Breast11 and Neoadjuvant Care in HER2-Positive Breast Cancer
Jules Cohen, MD
- Jules Cohen, MD
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Tracking Tumor Resistance in Metastatic Breast Cancer Care
On the Frontlines of Metastatic Breast Cancer
Tracking Tumor Resistance in Metastatic Breast Cancer Care
Ryan Quigley; Megan Kruse, MD
- Ryan Quigley
- Megan Kruse, MD
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Putting Patients First: Personalized Care in Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Putting Patients First: Personalized Care in Metastatic Breast Cancer
Ashley Baker, MSN, PMHNP; Giancarlo Moscol, M.D.
- Ashley Baker, MSN, PMHNP
- Giancarlo Moscol, M.D.

Prev
1
2
Next

1/2